Pfizer Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending June 29, 2025: 11.94%

Pfizer Inc. Return on Equity (ROE) is 11.94% for the Trailing 12 Months (TTM) ending June 29, 2025, a -521.10% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Pfizer Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending June 30, 2024 was -2.83%, a -112.80% change year over year.
  • Pfizer Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending July 02, 2023 was 22.14%, a -39.06% change year over year.
  • Pfizer Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending July 03, 2022 was 36.33%, a 86.78% change year over year.
  • Pfizer Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending July 04, 2021 was 19.45%, a -11.70% change year over year.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share